Cargando…

Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base

In multiple endocrine neoplasia type 1 (MEN1), nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) are the most frequently diagnosed NETs and a leading cause of MEN1-related death. The high prevalence and malignant potential of NF-pNETs outline the need for an evidence-based screening program,...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Treijen, Mark J C, van Beek, Dirk-Jan, van Leeuwaarde, Rachel S, Vriens, Menno R, Valk, Gerlof D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Mini-Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125714/ https://www.ncbi.nlm.nih.gov/pubmed/30202829 http://dx.doi.org/10.1210/js.2018-00087

Ejemplares similares

‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1
por: van Beek, Dirk-Jan, et al.
Publicado: (2018)

Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?
por: Naber, Myrthe R, et al.
Publicado: (2021)

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study
por: van Treijen, Mark J. C., et al.
Publicado: (2018)

The Importance of an Early and Accurate MEN1 Diagnosis
por: de Laat, Joanne M., et al.
Publicado: (2018)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs
por: van Vliembergen, Eline N. M., et al.
Publicado: (2023)

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice
por: van Beek, Dirk-Jan, et al.
Publicado: (2022)

Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up
por: Twigt, Bas A, et al.
Publicado: (2013)

Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)
por: van Beek, Dirk‐Jan, et al.
Publicado: (2019)

Assessing Outcomes After Adrenalectomy for Primary Aldosteronism – Early is Accurate: Retrospective Cohort Study
por: Suurd, Diederik P.D., et al.
Publicado: (2022)

Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort
por: van Beek, Dirk-Jan, et al.
Publicado: (2021)

Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2: Retrospective Cohort Analysis
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

Estrogen Receptors in Nonfunctioning Pituitary Neuroendocrine Tumors: Review on Expression and Gonadotroph Functions
por: Haydar Ali Tajuddin, Amalina, et al.
Publicado: (2020)

Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review
por: Park, Jane, et al.
Publicado: (2019)

ASO Author Reflections: Severe Morbidity After Major Surgery in Patients with MEN1
por: van Beek, Dirk-Jan, et al.
Publicado: (2021)

A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown – Retrospective cohort study
por: Suurd, Diederik P.D., et al.
Publicado: (2021)

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review
por: van den Broek, Medard F. M., et al.
Publicado: (2019)

Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series
por: van den Broek, Medard F. M., et al.
Publicado: (2021)

Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins
Publicado: (1993)

The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice
por: Piek, Marceline W., et al.
Publicado: (2022)

Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study
por: Ebbers, Sander C., et al.
Publicado: (2021)

A Blood-Based Polyamine Signature Associated With Disease Progression in Patients With Multiple Endocrine Neoplasia Type 1-Related Duodenopancreatic Neuroendocrine Tumors
por: Fahrmann, Johannes F, et al.
Publicado: (2021)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

(18)F-Fluorocholine PET–CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT–CT and ultrasound: A case report
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

Cancer Treatment–Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer
por: Taxel, Pamela, et al.
Publicado: (2018)

MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients
por: de Laat, Joanne M., et al.
Publicado: (2016)

Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET
por: Wang, Ruo-Qiang, et al.
Publicado: (2019)

Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study
por: Twigt, Bas A, et al.
Publicado: (2013)

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology
por: Droz, Jean-Pierre, et al.
Publicado: (2010)

Circulating immune cells in patients with surgically resected nonfunctional pancreatic neuroendocrine tumors
por: Jutric, Zeljka, et al.
Publicado: (2015)

Breath Metabolites to Diagnose Infection
por: Berna, Amalia Z, et al.
Publicado: (2021)

The great screen anomaly—a new frontier in product discovery through functional metagenomics
por: Ekkers, David Matthias, et al.
Publicado: (2011)

High Prevalence of Metabolic Syndrome Features in Patients Previously Treated for Nonfunctioning Pituitary Macroadenoma
por: Joustra, Sjoerd D., et al.
Publicado: (2014)

Multiple Cardiac Metastases from a Nonfunctioning Pancreatic Neuroendocrine Tumor
por: Choi, Yong Hyeok, et al.
Publicado: (2013)

Behavior of Small, Asymptomatic, Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PNETs)
por: Jung, Jae Gu, et al.
Publicado: (2015)

Nonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report
por: Xu, Baojin, et al.
Publicado: (2017)

Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors
por: Kim, Juwan, et al.
Publicado: (2020)

Insights of Outcome after Resection of Small Nonfunctioning Neuroendocrine Pancreatic Tumors
por: Figueira, Estela Regina Ramos, et al.
Publicado: (2021)

Optimal Lymphadenectomy in Patients with Well-Differentiated Nonfunctioning Pancreatic Neuroendocrine Neoplasms
por: Shintakuya, Ryuta, et al.
Publicado: (2023)

Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies
por: Paik, Woo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fobbsufvn9ifh825375hep24qo